Insider Trading › ALR › Insiders
ALR
ALR·Insider activity
—
No end-of-day price on record
ALR
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ALRS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of ALR were filed in the last 180 days. Newest filing Mar 20, 2023 (3 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by ALR insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
65Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of ALR common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
65 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| PORTNOY ADAM D.Director | Purchase | +22.4M | $1.31 | $29.3M | 22.4Mindirect | Mar 18, 2023 | Mar 20, 2023 | Form 4 ↗ |
| Cody Lauren C.EVP & CCO | Purchase | +40.0K | $2.52 | $101K | 40.0Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Guerdan MelissaSVP, Global Quality & Reg. | Sale | −2,500 | $54.00 | $135K | 0direct | Feb 1, 2016 | Feb 3, 2016 | Form 4 ↗ |
| Hargadon Robert BernardSVP, Global Human Resources | Purchase | +1,000 | $38.99 | $39K | 8,843direct | Nov 13, 2015 | Nov 16, 2015 | Form 4 ↗ |
| Hinrichs James F.Executive VP, CFO | Purchase | +10.0K | $39.97 | $400K | 30.0Kdirect | Nov 12, 2015 | Nov 12, 2015 | Form 4 ↗ |
| Guerdan MelissaSVP, Global Quality & Reg. | Sale | −5,135 | $52.00 | $267K | 0direct | Sep 3, 2015 | Sep 4, 2015 | Form 4 ↗ |
| Gladwell MarkSenior VP, Global Operations | Sale | −2,651 | $52.27 | $139K | 0direct | Sep 3, 2015 | Sep 4, 2015 | Form 4 ↗ |
| Guerdan MelissaSVP, Global Quality & Reg. | Sale | −5,000 | $50.48 | $252K | 5,135direct | Sep 1, 2015 | Sep 2, 2015 | Form 4 ↗ |
| Gladwell MarkSenior VP, Global Operations | Sale | −27.5K | $52.23 | $1.4M | 2,651direct | Aug 31, 2015 | Sep 2, 2015 | Form 4 ↗ |
| Malkani SanjayGlobal Pres., Toxicology | Sale | −31.5K | $54.60 | $1.7M | 6,222direct | Aug 14, 2015 | Aug 18, 2015 | Form 4 ↗ |
| Hinrichs James F.Executive VP, CFO | Purchase | +20.0K | $49.33 | $987K | 20.0Kindirect | Aug 7, 2015 | Aug 10, 2015 | Form 4 ↗ |
| Malkani SanjayGlobal Pres., Toxicology | Sale | −24.3K | $50.87 | $1.2M | 6,222direct | Jun 8, 2015 | Jun 10, 2015 | Form 4 ↗ |
| Malkani SanjayGlobal Pres., Toxicology | Sale | −15.7K | $52.18 | $818K | 6,222direct | Jun 4, 2015 | Jun 8, 2015 | Form 4 ↗ |
| BRIDGEN JOHNSr VP, Business Develop | Sale | −7,500 | $51.19 | $384K | 4,552direct | Jun 1, 2015 | Jun 2, 2015 | Form 4 ↗ |
| BRIDGEN JOHNSr VP, Business Develop | Sale | −22.6K | $51.17 | $1.2M | 4,552direct | May 29, 2015 | Jun 2, 2015 | Form 4 ↗ |
| Guerdan MelissaSVP, Global Quality & Reg. | Sale | −3,031 | $47.81 | $145K | 0direct | Apr 30, 2015 | May 4, 2015 | Form 4 ↗ |
| Guerdan MelissaSVP, Global Quality & Reg. | Sale | −2,500 | $50.00 | $125K | 0direct | Apr 6, 2015 | Apr 8, 2015 | Form 4 ↗ |
| Guerdan MelissaSVP, Global Quality & Reg. | Sale | −13.5K | $48.35 | $652K | 0direct | Mar 23, 2015 | Mar 25, 2015 | Form 4 ↗ |
| BRIDGEN JOHNSr VP, Business Develop | Sale | −25.0K | $48.53 | $1.2M | 4,552direct | Mar 17, 2015 | Mar 19, 2015 | Form 4 ↗ |
| Flakne CarlaVP, Chief Accounting Officer | Sale Amended | −8,500 | $48.99 | $416K | 3,252direct | Mar 16, 2015 | Apr 16, 2015 | Form 4 ↗ |
| Flakne CarlaVP, Chief Accounting Officer | Sale | −8,500 | $48.99 | $416K | 0direct | Mar 16, 2015 | Mar 18, 2015 | Form 4 ↗ |
| Gladwell MarkSenior VP, Global Operations | Sale | −792 | $44.66 | $35K | 0direct | Feb 23, 2015 | Feb 25, 2015 | Form 4 ↗ |
| Gladwell MarkSenior VP, Global Operations | Sale | −12.5K | $44.61 | $558K | 792direct | Feb 23, 2015 | Feb 25, 2015 | Form 4 ↗ |
| Flakne CarlaVP, Chief Accounting Officer | Sale Amended | −10.0K | $42.45 | $425K | 3,714direct | Jan 16, 2015 | Apr 27, 2016 | Form 4 ↗ |
| Flakne CarlaVP, Chief Accounting Officer | Sale | −10.0K | $42.45 | $425K | 3,252direct | Jan 16, 2015 | Jan 20, 2015 | Form 4 ↗ |
| GOLDBERG CAROL RDirector | Sale Amended | −110 | $39.46 | $4K | 40.0Kindirect | Jan 13, 2015 | Apr 12, 2016 | Form 4 ↗ |
| GOLDBERG CAROL RDirector | Sale | −110 | $39.46 | $4K | 0direct | Jan 13, 2015 | May 15, 2015 | Form 4 ↗ |
| BRIDGEN JOHNSr VP, Business Develop | Sale | −50.0K | $37.07 | $1.9M | 4,552direct | Dec 11, 2014 | Dec 12, 2014 | Form 4 ↗ |
| Teitel DaveChief Financial Officer | Sale | −10.0K | $35.07 | $351K | 5,002direct | Aug 15, 2014 | Aug 18, 2014 | Form 4 ↗ |
| Torchilin KateVP, Connected Health | Sale | −575 | $33.73 | $19K | 2,128direct | Dec 11, 2013 | Dec 13, 2013 | Form 4 ↗ |
| Torchilin KateVP, Connected Health | Sale | −7,972 | $33.73 | $269K | 2,028direct | Dec 11, 2013 | Dec 13, 2013 | Form 4 ↗ |
| HEMPEL PAUL TSVP Ethics & Compliance | Sale | −921 | $33.68 | $31K | 19.9Kdirect | Nov 13, 2013 | Nov 14, 2013 | Form 4 ↗ |
| HEMPEL PAUL TSVP Ethics & Compliance | Sale | −3,655 | $33.75 | $123K | 19.9Kdirect | Nov 12, 2013 | Nov 14, 2013 | Form 4 ↗ |
| Teitel DaveChief Financial Officer | Sale | −10.0K | $31.73 | $317K | 4,506direct | Aug 15, 2013 | Aug 16, 2013 | Form 4 ↗ |
| Cotton Michael LesterGlobal Pres, Health Mgmt | Sale | −12.5K | $33.82 | $423K | 0direct | Aug 5, 2013 | Aug 7, 2013 | Form 4 ↗ |
| Cotton Michael LesterGlobal Pres, Health Mgmt | Sale | −8,750 | $25.86 | $226K | 0direct | May 31, 2013 | Jun 4, 2013 | Form 4 ↗ |
| Post JimPresident, Acute Care | Sale | −1,075 | $23.37 | $25K | 0direct | Mar 7, 2013 | Mar 11, 2013 | Form 4 ↗ |
| QUELCH JOHNDirector | Sale | −20.2K | $23.49 | $475K | 9,780direct | Mar 5, 2013 | Mar 7, 2013 | Form 4 ↗ |
| EYLENBOSCH HILDEPresident, Alere International | Sale | −2,391 | $22.69 | $54K | 30.2Kdirect | Mar 1, 2013 | Mar 5, 2013 | Form 4 ↗ |
| Post JimPresident, Alere NA | Sale | −840 | $18.77 | $16K | 502direct | Aug 23, 2012 | Aug 27, 2012 | Form 4 ↗ |
| TOOHEY DAVIDPresident, Intl Bus. Operation | Sale | −151 | $18.28 | $3K | 9,087direct | Aug 14, 2012 | Aug 16, 2012 | Form 4 ↗ |
| BRIDGEN JOHNSr VP, Business Develop | Sale | −11.7K | $18.96 | $222K | 2,633direct | Aug 7, 2012 | Aug 9, 2012 | Form 4 ↗ |
| BRIDGEN JOHNVP, Strategic Business Develop | Sale | −4,752 | $20.00 | $95K | 2,633direct | Jul 19, 2012 | Jul 23, 2012 | Form 4 ↗ |
| HEMPEL PAUL TSVP Ethics & Compliance | Sale | −1,700 | $19.03 | $32K | 18.5Kdirect | Jun 13, 2012 | Jun 15, 2012 | Form 4 ↗ |
| HEMPEL PAUL TSVP Ethics & Compliance | Sale | −8,213 | $19.00 | $156K | 20.2Kdirect | Jun 13, 2012 | Jun 15, 2012 | Form 4 ↗ |
| HEMPEL PAUL TSVP Ethics & Compliance | Sale | −200 | $19.01 | $4K | 28.4Kdirect | Jun 13, 2012 | Jun 15, 2012 | Form 4 ↗ |
| BRIDGEN JOHNVP, Strategic Business Develop | Sale | −4,357 | $25.00 | $109K | 2,633direct | Mar 7, 2012 | Mar 9, 2012 | Form 4 ↗ |
| Underwood ThomasCEO, Alere Health LLC | Sale | −750 | $26.02 | $20K | 1,500direct | Feb 16, 2012 | Feb 21, 2012 | Form 4 ↗ |
| BRIDGEN JOHNVP, Strategic Business Develop | Sale | −5,446 | $25.10 | $137K | 2,633direct | Feb 7, 2012 | Feb 9, 2012 | Form 4 ↗ |
| BRIDGEN JOHNVP, Strategic Business Develop | Sale | −6,808 | $25.00 | $170K | 2,633direct | Feb 2, 2012 | Feb 6, 2012 | Form 4 ↗ |
| MCALEER JEROME FVP, Research & Development · Director | Sale | −116.8K | $22.25 | $2.6M | 297.3Kdirect | Nov 28, 2011 | Nov 30, 2011 | Form 4 ↗ |
| SCOTT DAVIDChief Technical Officer · Director | Sale Amended | −164.2K | $26.02 | $4.3M | 475.7Kdirect | Nov 16, 2011 | Dec 1, 2011 | Form 4 ↗ |
| SCOTT DAVIDChief Technical Officer · Director | Sale | +164.2K | $26.02 | $4.3M | 475.7Kdirect | Nov 16, 2011 | Nov 18, 2011 | Form 4 ↗ |
| EYLENBOSCH HILDEChief Commercial Officer | Sale | −17.2K | $26.02 | $448K | 30.1Kdirect | Nov 15, 2011 | Nov 17, 2011 | Form 4 ↗ |
| Roosevelt James Jr.Director | Purchase | +4,444 | $22.50 | $100K | 4,444direct | Aug 23, 2011 | Aug 24, 2011 | Form 4 ↗ |
| Underwood ThomasCEO, Alere Health LLC | Purchase | +1,500 | $23.44 | $35K | 1,500direct | Aug 11, 2011 | Aug 12, 2011 | Form 4 ↗ |
| Hargadon Robert BernardVP, Global Culture & Performan | Purchase | +600 | $22.90 | $14K | 3,000direct | Aug 9, 2011 | Aug 10, 2011 | Form 4 ↗ |
| Hargadon Robert BernardVP, Global Culture & Performan | Purchase | +1,400 | $22.93 | $32K | 2,400direct | Aug 9, 2011 | Aug 10, 2011 | Form 4 ↗ |
| HEMPEL PAUL TSVP Ethics & Compliance | Sale | −13.0K | $36.75 | $479K | 17.1Kdirect | Mar 15, 2011 | Mar 17, 2011 | Form 4 ↗ |
| HEMPEL PAUL TSVP Ethics & Compliance | Sale | −6,175 | $36.76 | $227K | 30.1Kdirect | Mar 15, 2011 | Mar 17, 2011 | Form 4 ↗ |
| HEMPEL PAUL TSr VP, LD & Legal Affairs | Sale | −1,020 | $29.22 | $30K | 9,984direct | Nov 12, 2010 | Nov 16, 2010 | Form 4 ↗ |
| Adashi EliDirector | Purchase | +850 | $28.80 | $24K | 850direct | Aug 27, 2010 | Aug 31, 2010 | Form 4 ↗ |
| QUELCH JOHNDirector | Purchase | +4,600 | $28.36 | $130K | 5,000direct | Jul 30, 2010 | Aug 3, 2010 | Form 4 ↗ |
| QUELCH JOHNDirector | Purchase | +400 | $28.24 | $11K | 400direct | Jul 30, 2010 | Aug 3, 2010 | Form 4 ↗ |
| BRIDGEN JOHNVP, Strategic Business Develop | Sale | −3,486 | n/c | — | 2,633direct | Apr 26, 2010 | Apr 30, 2012 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →